GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus

NCT01356160 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

351

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: GS-5885
DRUG: GS-9451
BIOLOGICAL: peginterferon alfa-2a
DRUG: ribavirin tablet
DRUG: GS-9451 Placebo

Sponsor

Gilead Sciences